Drug Shortage Report for MINT-ANASTROZOLE
| Report ID | 217369 |
| Drug Identification Number | 02393573 |
| Brand name | MINT-ANASTROZOLE |
| Common or Proper name | Anastrazole |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ANASTROZOLE |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 count blisters |
| ATC code | L02BG |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-18 |
| Estimated end date | 2024-04-30 |
| Actual end date | 2024-03-25 |
| Shortage status | Resolved |
| Updated date | 2024-03-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-03-26 | English | Compare |
| v4 | 2024-03-25 | French | Compare |
| v3 | 2024-03-25 | English | Compare |
| v2 | 2024-01-26 | French | Compare |
| v1 | 2024-01-26 | English | Compare |
Showing 1 to 5 of 5